Viet Nam
Tuberculosis profile
| High TB burden | High HIV burden | High MDR-TB burden |
Population  2012 91 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 18 (12–25) 20 (13–27)
Mortality (HIV+TB only) 2.1 (1.8–2.7) 2.4 (2–2.9)
Prevalence  (includes HIV+TB) 200 (78–370) 218 (86–410)
Incidence  (includes HIV+TB) 130 (99–170) 147 (109–192)
Incidence (HIV+TB only) 9.3 (6.9–12) 10 (7.6–13)
Case detection, all forms (%) 76 (59–100)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 51 033 (54) Relapse 7 259 (80)
Smear-negative 21 706 (23) Treatment after failure 567 (6)
Smear-unknown / not done     Treatment after default 494 (5)
Extrapulmonary 18 904 (20) Other 733 (8)
Other 3 210 (3)      
Total new 94 853   Total retreatment 9 053  
           
Other (history unknown)          
Total new and relapse 102 112   Total cases notified 103 906  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 3.0    
Age < 15 142    
Laboratories 2012
Smear (per 100 000 population) 0.9
Culture (per 5 million population) 1.4
Drug susceptibility testing (per 5 million population) 0.1
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 93   Is rifampicin used
throughout treatment for
new patients?
No
New smear-negative/extrapulmonary 93  
Retreatment 82  
TB/HIV 2012 Number (%)
TB patients with known HIV status 68 259 (66)
HIV-positive TB patients 4 775 (7)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 3 486 (73)
HIV-positive TB patients on antiretroviral therapy (ART) 2 232 (47)
HIV-positive people screened for TB    
HIV-positive people provided with IPT 5 663  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.7 (2–3.7) 19 (14–25)
MDR-TB cases among notified pulmonary
TB cases
2 100 (1 500–2 800) 1 700 (1 300–2 300)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB      
Laboratory-confirmed MDR-TB cases     273
Patients started on MDR-TB treatment     713
Financing TB control 2013
National TB programme budget (US$ millions) 66
% Funded domestically 8%
% Funded internationally 20%
% Unfunded 72%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-18 Data: www.who.int/tb/data